- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Your mother was right: you can put your eye out with that thing
Doctors in this week’s British Medical Journal are warning about the use of high-powered handheld laser pointers after treating a young patient with serious eye injuries.
Doctors in this week’s British Medical Journal are warning about the use of high-powered handheld laser pointers after treating a young patient with serious eye injuries.
Dr Kimia Ziahosseini and colleagues from the Royal Liverpool University Hospital and Manchester Royal Eye Hospital describe the case of a teenager who presented with central scotomas (dark spots) after he bought a green diode laser pointer over the Internet and shone the laser beam into his eyes while playing with it.
His visual acuity was poor and tests revealed burns to the surface of the eye and disturbances to the retina, the light-sensitive tissue at the back of the eye. Two months later, his visual acuity improved but some retinal damage remained.
The authors warn that, although lasers may cause only a transient afterimage, they can lead to permanent retinal damage and visual loss in later years.
The U.K. Health Protection Agency has received no previous reports of such injury from laser pointers, they write. It advises that laser products sold to the general public for use as laser pointers should be restricted to devices with laser power less than 1 mW, in accordance with the British Standard, and be accompanied by sufficient information on their safe operation.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
